D-1255-2014 Class III Terminated
FDA drug recall D-1255-2014 was initiated by Upsher Smith Laboratories, Inc. on Apr 14, 2014 and is designated Class III. Reason for recall: Labeling: Missing Label; Three cases of product (total of 36 bottles) were packaged without the primary label on the bottle. The cases were, however, packaged in the correct finished product shipper… The recall status is terminated (terminated Jul 1, 2014). Affected quantity: 1,185 bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Apr 30, 2014
- Initiation Date
- Apr 14, 2014
- Termination Date
- Jul 1, 2014
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 1,185 bottles
Product description
Oxandrolone Tablets, USP, 10 mg, Rx Only, C-III, 60-count bottle, Manufactured for: Upsher-Smith Labs, Minneapolis, MN 55447, by: Pharmaceutics International, Inc., Hunt Valley, MD 21031, NDC 0245-0272-06
Reason for recall
Labeling: Missing Label; Three cases of product (total of 36 bottles) were packaged without the primary label on the bottle. The cases were, however, packaged in the correct finished product shipper, labeled with the correct shipper bar code label, sealed with tamper-evident tape and erroneously shipped to Upsher-Smith.
Distribution pattern
Nationwide
Code information
Lot #2802.042A, Exp. 10/2015
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-1255-2014
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026